<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/19/2492" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/19/2492/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/19/2492/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_2492"><akn:num>2492</akn:num><akn:heading>Tariff treatment of products of uncooperative major drug producing or drug-transit countries</akn:heading><akn:content><akn:p>§ 2492. Tariff treatment of products of uncooperative major drug producing or drug-transit countries(a) Required action by PresidentSubject to subsection (b), for every major drug producing country and every major drug-transit country, the President shall, on or after March 1, 1987, and March 1 of each succeeding year, to the extent considered necessary by the President to achieve the purposes of this subchapter—(1) deny to any or all of the products of that country tariff treatment under the Generalized System of Preferences, the Caribbean Basin Economic Recovery Act [19 U.S.C. 2701 et seq.], or any other law providing preferential tariff treatment;

(2) apply to any or all of the dutiable products of that country an additional duty at a rate not to exceed 50 percent ad valorem or the specific rate equivalent;

(3) apply to one or more duty-free products of that country a duty at a rate not to exceed 50 percent ad valorem;

(4) take the steps described in subsection (d)(1) or (d)(2), or both, to curtail air transportation between the United States and that country;

(5) withdraw the personnel and resources of the United States from participation in any arrangement with that country for the pre-clearance of customs by visitors between the United States and that country; or

(6) take any combination of the actions described in paragraphs (1) through (5).


(b) Certifications; Congressional action(1)(A) Subject to paragraph (3), subsection (a) shall not apply with respect to a country if the President determines and certifies to the Congress, at the time of the submission of the report required by section 2291h of title 22, that—(i) during the previous year the country has cooperated fully with the United States, or has taken adequate steps on its own—(I) in satisfying the goals agreed to in an applicable bilateral narcotics agreement with the United States (as described in paragraph (B)) or a multilateral agreement which achieves the objectives of paragraph (B),

(II</akn:p></akn:content><akn:subsection eId="subsec_2492_a"><akn:num>(a)</akn:num><akn:heading>Required action by President</akn:heading><akn:content><akn:p>(a) Required action by President Subject to subsection (b), for every major drug producing country and every major drug-transit country, the President shall, on or after March 1, 1987, and March 1 of each succeeding year, to the extent considered necessary by the President to achieve the purposes of this subchapter—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2492_b"><akn:num>(b)</akn:num><akn:heading>Certifications; Congressional action</akn:heading><akn:content><akn:p>(b) Certifications; Congressional action</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2492_c"><akn:num>(c)</akn:num><akn:heading>Duration of action</akn:heading><akn:content><akn:p>(c) Duration of action The action taken by the President under paragraph (1), (2), or (3) of subsection (a) shall apply to the products of a foreign country that are entered, or withdrawn from warehouse for consumption, during the period that such action is in effect.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2492_d"><akn:num>(d)</akn:num><akn:heading>Presidential action regarding aviation</akn:heading><akn:content><akn:p>(d) Presidential action regarding aviation</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2492_e"><akn:num>(e)</akn:num><akn:heading>Standards and guidelines for determining major drug-transit countries</akn:heading><akn:content><akn:p>(e) Standards and guidelines for determining major drug-transit countries For each calendar year, the Secretary of State, after consultation with the appropriate committees of the Congress, shall establish numerical standards and other guidelines for determining which countries will be considered to be major drug-transit countries under section 2495(3)(A) and (B) of this title.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>